CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing innovative methods to create modified ribosomally synthesized and post-translationally modified peptides (RiPPs) for drug discovery. By utilizing interchangeable leader peptide technology, the project aims to generate diverse and novel compounds that can target specific pathogens, enh…
Natural sources have been highly important for the discovery of new drugs, offering compounds that possess exciting and potent bioactivities.
The development of many promising natural products is significantly hampered by the difficulties associated with the synthesis of novel analogs.
The family of ribosomally synthesized and post-translationally modified peptide (RiPP) natural products offers a plethora of different, promising bioactivities and highly diverse scaffolds. I propose to develop tw…
GOTTFRIED WILHELM LEIBNIZ UNIVERSITAET HANNOVER
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
